Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
0.150
-0.015 (-8.83%)
At close: Nov 20, 2024, 4:00 PM
0.135
-0.014 (-9.68%)
Pre-market: Nov 21, 2024, 5:49 AM EST
Apollomics Market Cap
Apollomics has a market cap or net worth of $16.52 million as of November 21, 2024. Its market cap has decreased by -77.47% in one year.
Market Cap
16.52M
Enterprise Value
-4.69M
1-Year Change
-77.47%
Ranking
Category
Stock Price
$0.15
Market Cap Chart
Since October 8, 2021, Apollomics's market cap has decreased from $118.20M to $16.52M, a decrease of -86.03%. That is a compound annual growth rate of -46.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 18.00M | -79.14% |
| Dec 29, 2023 | 86.30M | -37.96% |
| Dec 30, 2022 | 139.10M | 4.35% |
| Dec 31, 2021 | 133.30M | 12.77% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEI Pharma | 19.06M |
| Akari Therapeutics, | 18.77M |
| Palatin Technologies | 18.64M |
| Kairos Pharma | 18.62M |
| ProPhase Labs | 18.14M |
| bioAffinity Technologies | 17.94M |
| Cognition Therapeutics | 17.82M |
| Retractable Technologies | 17.51M |